REDHILL BIOPHARMA LTD reports a Return on Equity (ROE) of -193.70%.

What is RDHL's dividend yield?

REDHILL BIOPHARMA LTD offers a dividend yield of 0.00%.

What is RDHL's Deepscope Quality Score?

Deepscope rates RDHL's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy RDHL?

Deepscope's AI Timing Score for RDHL is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does RDHL belong to?

REDHILL BIOPHARMA LTD is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.

Cổ phiếu RDHL (NASDAQ) | REDHILL BIOPHARMA LTD

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

RDHL

REDHILL BIOPHARMA LTD

USD 1.03

0.03 (3.00%) Day Change

Watchlist Portfolio Compare Chart

0.04

D/E

-193.7%

ROE

-32.6%

ROA

0.00%

Div Yield

Data partially updated

REDHILL BIOPHARMA LTD
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.03 Price 0.03 (3.00%) Day Change	NEWS SCORE: 73

RDHL Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	73
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.03
PBV / Sector	1.17 / 2.76 GREAT
Earning Per Share	-1.70

PE / Sector	N/A / 23.64
PEG or PE/Growth / Sector	N/A / 0.13
Average 1M Daily Value	0.11 M GREAT
Average 1W Daily Value	0.11 M GREAT

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-102.06 / 15.98
NPM Average (%) / Sector	-20.91 / -16.38
NPM Change Average (%) / Sector	-132.48 / 113.39
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-32.62 / 8.16
ROA Average (%) / Sector	-4.30 / 2.38
ROA Change Average (%) / Sector	314.14 / 108.63 GREAT
ROE (%) / Sector	-193.70 / -0.19
ROE Average (%) / Sector	255.36 / 7.40 GREAT
ROE Change Average (%) / Sector	579.31 / 371.95 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.53
Dividend Average (%) / Sector	N/A / 3.08
Dividend Change Average (%) / Sector	N/A / 14.88

Chi tiết đăng ký

Analyze Date	2026-06-06 09:09:26
Symbol	RDHL
Name	REDHILL BIOPHARMA LTD
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	5.19 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	5.00 / 9,835.56

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 21 Ha?arba?a Street, Tel Aviv-Yafo, Israel, 6473921

Phone: 972 3 541 3131

Website: https://www.redhillbio.com

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear radiation protection; and host directed anti-viral; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 that is in Phase 3 clinical trial for the treatment of pulmonary Mycobacterium avium complex disease in adults. The company was incorporated in 2009 and is headquartered in Tel Aviv-Yafo, Israel.